Drug response is typically measured using various clinical endpoints such as tumor shrinkage, progression-free survival, and overall survival. Radiographic imaging, blood tests, and biopsies are commonly used to assess these endpoints. Biomarkers can also play a significant role in predicting how a patient might respond to a specific drug.
